NMR Earnings

NMR reported its FY2026Q1 earnings on 2025-07-29, showcasing a revenue of 523.32B against an estimate of 437.00B, resulting in a 19.75% surprise. The EPS was 0, surpassing the expected 0.25 by 0% . The stock experienced a 4.64% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following NMR's FY2026Q1 earnings announcement on 2025-07-29, the stock price moved by 4.64% on the day of the release. Over the subsequent five days, it saw a 0.00% change. Historically, NMR's stock price tends to shift by an average of -0.01% in the 10 days leading up to earnings and +2.55% in the 10 days following, providing insight into potential market.

For 2026/Q3, analysts estimate NMR’s annual revenue to reach 523.00B, while the EPS is projected at 0.24. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between NMR's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were No Change by 0%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, NMR's stock price typically moves by -0.01% in the 10 days before its earnings and +2.55% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of 0.24 and revenue of 523.00B.

The earnings call summary presents mixed signals. Financial performance shows growth in Tier 1 Capital and Risk-Weighted Assets, but there's a decline in the Common Equity Tier 1 Ratio. The Q&A reveals concerns about volatility and uncertainties in net inflows, while management's unclear responses add to uncertainty. The buyback plan and strong Global Markets performance are positives, but the lack of clarity on future strategies and the impact of regulatory changes temper enthusiasm. Overall, the sentiment remains neutral due to these mixed factors.